- Home
- WPC vs EXEL Comparison
WPC vs EXEL Comparison
Compare WPC & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPC
- EXEL
- Stock Information
- Founded
- WPC 1973
- EXEL 1994
- Country
- WPC United States
- EXEL United States
- Employees
- WPC N/A
- EXEL N/A
- Industry
- WPC Real Estate Investment Trusts
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WPC Real Estate
- EXEL Health Care
- Exchange
- WPC Nasdaq
- EXEL Nasdaq
- Market Cap
- WPC 13.7B
- EXEL 12.0B
- IPO Year
- WPC 1998
- EXEL 2000
- Fundamental
- Price
- WPC $61.68
- EXEL $44.47
- Analyst Decision
- WPC Hold
- EXEL Buy
- Analyst Count
- WPC 13
- EXEL 18
- Target Price
- WPC $93.08
- EXEL $44.24
- AVG Volume (30 Days)
- WPC 1.2M
- EXEL 3.6M
- Earning Date
- WPC 07-29-2025
- EXEL 07-28-2025
- Dividend Yield
- WPC 5.78%
- EXEL N/A
- EPS Growth
- WPC N/A
- EXEL 237.58
- EPS
- WPC 1.94
- EXEL 2.20
- Revenue
- WPC $1,595,990,000.00
- EXEL $2,298,922,000.00
- Revenue This Year
- WPC $4.80
- EXEL $9.93
- Revenue Next Year
- WPC $5.57
- EXEL $13.17
- P/E Ratio
- WPC $31.72
- EXEL $20.18
- Revenue Growth
- WPC N/A
- EXEL 24.49
- 52 Week Low
- WPC $52.91
- EXEL $22.20
- 52 Week High
- WPC $66.10
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- WPC 44.26
- EXEL 53.42
- Support Level
- WPC $61.09
- EXEL $44.03
- Resistance Level
- WPC $63.88
- EXEL $45.52
- Average True Range (ATR)
- WPC 1.06
- EXEL 1.44
- MACD
- WPC -0.19
- EXEL -0.06
- Stochastic Oscillator
- WPC 21.15
- EXEL 22.78
About WPC W. P. Carey Inc. REIT
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.